ELEDON PHARMACEUTICALS INC (ELDN) Stock Balance Sheet
NASDAQ:ELDN - Nasdaq - US28617K1016 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 8.50M | 20.55M | 4.61M | 56.40M | 84.80M | |||
| Marketable Securities | 116.39M | 119.63M | 46.49M | N/A | N/A | |||
| Receivables | 761.00K | N/A | N/A | N/A | 0.00 | |||
| Other Current Assets | 2.08M | 3.55M | 5.03M | 3.10M | 3.50M | |||
| Total Current Assets | 127.72M | 143.73M | 56.13M | 59.50M | 88.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 850.00K | 926.00K | 365.00K | 700.00K | 800.00K | |||
| Goodwill | N/A | N/A | N/A | 0.00 | 48.60M | |||
| Intangibles | 32.39M | 32.39M | 32.39M | 32.40M | 32.40M | |||
| Other Non-Current Assets | 354.00K | 363.00K | 186.00K | 200.00K | 400.00K | |||
| Total Non-Current Assets | 33.59M | 33.67M | 32.94M | 33.30M | 82.20M | |||
| TOTAL ASSETS | 161.31M | 177.41M | 89.07M | 92.80M | 170.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 6.28M | 5.74M | 2.93M | 4.30M | 2.60M | |||
| Accounts Payable | 2.90M | 5.83M | 967.00K | 2.20M | 1.80M | |||
| Total Current Liabilities | 9.19M | 11.58M | 3.90M | 6.50M | 4.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 2.18M | 2.18M | 1.75M | 1.80M | 1.80M | |||
| Other Non-Current Liabilities | 35.36M | 45.51M | 0.00 | 400.00K | 400.00K | |||
| Total Non-Current Liabilities | 37.54M | 47.69M | 1.75M | 2.10M | 2.20M | |||
| TOTAL LIABILITIES | 46.73M | 59.27M | 5.65M | 8.60M | 6.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -362.08M | -355.59M | -243.19M | -202.90M | -114.90M | |||
| Additional Paid In Capital | 476.62M | 473.64M | 326.59M | 287.00M | 278.90M | |||
| Common Shares | 60.00K | 60.00K | 24.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -18.00K | 26.00K | N/A | N/A | N/A | |||
| Shares Outstanding | 59.88M | 59.79M | 24.21M | 13.80M | 14.30M | |||
| Tangible Book Value per Share | 1.37 | 1.43 | 2.11 | 3.75 | 5.80 | |||
| Total Shareholders' Equity | 114.58M | 118.14M | 83.42M | 84.20M | 164.00M | |||
| TOTAL LIABILITIES AND EQUITY | 161.31M | 177.41M | 89.07M | 92.80M | 170.50M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 13.91 | 12.42 | 14.41 | 9.15 | 20.07 | |||
| Return On Assets (ROA) | -29.74% | -20.40% | -130.84% | -94.80% | -20.24% | |||
| Return On Equity (ROE) | -41.87% | -30.63% | -139.70% | -104.48% | -21.04% | |||
All data in USD , ROIC based on taxRate of 0.21